What top creators are saying about Semler Scientific, Inc.(SMLR)

Presented as a merger arbitrage opportunity to acquire shares of ASST at a potential discount, as SMLR trades at a very low MNAV (Market Cap to Net Asset Value) of 0.85. This is recommended for investors who are already bullish on ASST.

The company is being acquired in an all-stock deal, suggesting consolidation in a sector where valuations for Bitcoin treasury companies have been 'under strain'.

Is being acquired in an all-stock deal.

Was acquired at a 210% premium, serving as 'proof' that undervalued Bitcoin-holding companies are attractive takeover targets. This event is seen as bullish for the entire sector.

Mentioned as 'SmarterWeb', it is highlighted for its significant underperformance (down -48% in the past month) compared to MSTR.

Offers a unique opportunity to buy Bitcoin at a 6% discount to its current market price through its stock.

Could represent a value opportunity as it is trading at an 8% discount to the value of its Bitcoin holdings.

Used as a peer comparison to KULR, with the speaker arguing that the market places little value on its core medical device business, making it a less compelling 'Bitcoin treasury' stock.

An example of a 'treasury' company providing leveraged exposure to Bitcoin. These stocks typically experience a sharp pump on their BTC strategy announcement before settling at a premium to their Net Asset Value (NAV).

Highlighted as part of the positive corporate adoption trend for Bitcoin, having added $187 million worth of BTC to its treasury.

The company's inaction on buying Bitcoin is seen as understandable and neutral because its low 'price to NAV' means issuing shares to buy Bitcoin would destroy shareholder value.

Described as a 'riskier horse' and a speculative, high-volatility play. Its price movements are significant and can be driven by market sentiment and hope for future actions, like equity issuance.